Literature DB >> 14654749

Evidence for carotid and radial artery wall subclinical lesions in renal fibromuscular dysplasia.

Pierre Boutouyrie1, Anne-Paule Gimenez-Roqueplo, Erika Fine, Brigitte Laloux, Béatrice Fiquet-Kempf, Pierre-François Plouin, Xavier Jeunemaitre, Stéphane Laurent.   

Abstract

BACKGROUND: Fibromuscular dysplasia (FD) is a non-atherosclerotic, non-inflammatory arterial disease of unknown cause, and most frequently affects the renal and internal carotid arteries. Our objectives were to determine whether quantitative and qualitative lesions could be detected by high-resolution echotracking techniques at two arterial sites generally considered as free of echographic lesions: the common carotid and the radial arteries, and to compare their frequency with a control population. METHODS AND
RESULTS: We studied 70 patients with renal FD and 70 control subjects matched for age, sex and systolic blood pressure. Arterial parameters were determined using non-invasive high-resolution echotracking systems. Carotid B-mode scans and radiofrequency signals were analysed and quoted by three observers blinded to diagnosis. FD patients had thicker carotid (+12%, P < 0.001) and radial arteries (+10%, P < 0.05) than controls. Abnormal echographic patterns of the carotid artery, including supernumerary interfaces and/or interruption of the blood-intima acoustic interfaces, were frequently observed in FD patients and rarely in control subjects. These abnormalities were quantified with a phenotypic score ranging from 2 to 7, and their sensitivity and specificity were 73 and 81%, respectively, as markers of FD. Having a phenotypic score > 3 conferred an odds ratio of 12.9 (95% CI 5.7-29.3) of having renal FD.
CONCLUSION: We defined a new carotid phenotype in FD patients using a non-invasive echotracking system, and showed an increased wall thickness and distensibility of the radial artery. These data indicate the presence of subclinical lesions at arterial sites distant from the renal arteries, suggesting that renal FD is not a focal but a systemic arterial disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14654749     DOI: 10.1097/00004872-200312000-00017

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  10 in total

1.  Cerebrovascular Complications of Fibromuscular Dysplasia.

Authors:  Megan C. Leary; Anna Finley; Louis R. Caplan
Journal:  Curr Treat Options Cardiovasc Med       Date:  2004-06

Review 2.  Diagnosis and treatment of renal artery stenosis.

Authors:  Pierre-François Plouin; Liesbeth Bax
Journal:  Nat Rev Nephrol       Date:  2010-01-26       Impact factor: 28.314

3.  Prevalence and predictors of carotid wall triple line pattern in a general population sample.

Authors:  Andrew Ryabikov; Sofia Malyutina; Julian Halcox; Yuri Nikitin; Michael Marmot; Martin Bobak
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-04-14       Impact factor: 8.311

Review 4.  Current progress in clinical, molecular, and genetic aspects of adult fibromuscular dysplasia.

Authors:  Alexandre Persu; Piotr Dobrowolski; Heather L Gornik; Jeffrey W Olin; David Adlam; Michel Azizi; Pierre Boutouyrie; Rosa Maria Bruno; Marion Boulanger; Jean-Baptiste Demoulin; Santhi K Ganesh; Tomasz J Guzik; Magdalena Januszewicz; Jason C Kovacic; Mariusz Kruk; Peter de Leeuw; Bart L Loeys; Marco Pappaccogli; Melanie H A M Perik; Emmanuel Touzé; Patricia Van der Niepen; Daan J L Van Twist; Ewa Warchoł-Celińska; Aleksander Prejbisz; Andrzej Januszewicz
Journal:  Cardiovasc Res       Date:  2022-01-07       Impact factor: 10.787

5.  PHACTR1 Is a Genetic Susceptibility Locus for Fibromuscular Dysplasia Supporting Its Complex Genetic Pattern of Inheritance.

Authors:  Soto Romuald Kiando; Nathan R Tucker; Luis-Jaime Castro-Vega; Alexander Katz; Valentina D'Escamard; Cyrielle Tréard; Daniel Fraher; Juliette Albuisson; Daniella Kadian-Dodov; Zi Ye; Erin Austin; Min-Lee Yang; Kristina Hunker; Cristina Barlassina; Daniele Cusi; Pilar Galan; Jean-Philippe Empana; Xavier Jouven; Anne-Paule Gimenez-Roqueplo; Patrick Bruneval; Esther Soo Hyun Kim; Jeffrey W Olin; Heather L Gornik; Michel Azizi; Pierre-François Plouin; Patrick T Ellinor; Iftikhar J Kullo; David J Milan; Santhi K Ganesh; Pierre Boutouyrie; Jason C Kovacic; Xavier Jeunemaitre; Nabila Bouatia-Naji
Journal:  PLoS Genet       Date:  2016-10-28       Impact factor: 5.917

Review 6.  Genomics of Fibromuscular Dysplasia.

Authors:  Silvia Di Monaco; Adrien Georges; Jean-Philippe Lengelé; Miikka Vikkula; Alexandre Persu
Journal:  Int J Mol Sci       Date:  2018-05-21       Impact factor: 5.923

Review 7.  The complex genetic basis of fibromuscular dysplasia, a systemic arteriopathy associated with multiple forms of cardiovascular disease.

Authors:  Adrien Georges; Nabila Bouatia-Naji
Journal:  Clin Sci (Lond)       Date:  2022-08-31       Impact factor: 6.876

Review 8.  Fibromuscular dysplasia.

Authors:  Pierre-François Plouin; Jérôme Perdu; Agnès La Batide-Alanore; Pierre Boutouyrie; Anne-Paule Gimenez-Roqueplo; Xavier Jeunemaitre
Journal:  Orphanet J Rare Dis       Date:  2007-06-07       Impact factor: 4.123

9.  The triple line pattern on carotid intima media thickness imaging and its relationship to cardiovascular risk factors in patients on lipid lowering therapy.

Authors:  Tania A Singh; Todd C Villines; Allen J Taylor
Journal:  Vasc Health Risk Manag       Date:  2014-06-20

10.  Spontaneous neck hematoma in a patient with fibromuscular dysplasia: a case report and a review of the literature.

Authors:  Oded Cohen; Moshe Yehuda; Meital Adi; Yonatan Lahav; Doron Halperin
Journal:  Case Rep Otolaryngol       Date:  2013-09-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.